Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 12/02 10:14:59 pm
75.5 USD   -2.98%
12/02 VERTEX PHARMACE : VRTX) Files An 8-K Departure of Directors or Certa..
11/29 NASDAQ 100 MOVE : Bmrn, nflx
11/11 NASDAQ 100 MOVE : Alxn, nvda
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Number of employees : 1 950 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals580.42100%1,032100% +77.86%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States361.0762.2%763.3273.9% +111.4%
Europe197.6134%219.6021.3% +11.13%
Other21.733.7%49.424.8% +127.45%
Managers
NameAgeSinceTitle
Jeff Leiden602009Chairman, President & Chief Executive Officer
Simon Bedson, MBA-2011SVP & GM-International Commercial Operations
Ian F. Smith502001Chief Financial Officer & Executive Vice President
Jeffrey A. Chodakewitz, MD602014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD512012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD651989Director
Bruce I. Sachs, MBA561998Lead Independent Director
Elaine S. Ullian681997Lead Independent Director
Margaret G. McGlynn, MBA562011Independent Director
Terrence C. Kearney, MBA612011Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 248,033,389 245,924,018 99.1% 0 0.0% 99.1%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 23,483,388 9.47%
Fidelity Management & Research Co. 22,472,869 9.06%
Capital Research & Management Co. (World Investors) 22,292,383 8.99%
The Vanguard Group, Inc. 15,602,091 6.29%
Wellington Management Co. LLP 14,423,839 5.82%
BlackRock Fund Advisors 12,755,097 5.14%
SSgA Funds Management, Inc. 8,779,211 3.54%
Columbia Management Investment Advisers LLC 7,701,905 3.11%
JPMorgan Investment Management, Inc. 7,665,799 3.09%
ClearBridge Investments LLC 7,299,009 2.94%
Holdings
NameEquities%Valuation
Crispr Therapeutics AG (CRSP) 2,472,3016.28%45,119,493 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-35.14%19 302
AMGEN, INC.-11.25%105 927
GILEAD SCIENCES, INC.-27.17%95 964
CELGENE CORPORATION-1.78%92 148
REGENERON PHARMACEUTIC..-31.34%39 610
ACTELION LTD40.40%20 855
GENMAB A/S32.53%10 276
TESARO INC149.92%6 983
HUALAN BIOLOGICAL ENGI..--.--%4 797
TONGHUA DONGBAO PHARMA..-83.11%4 741
EXELIXIS, INC.200.00%4 732
NEUROCRINE BIOSCIENCES..-17.89%3 755
CHINA BIOLOGIC PRODUCT..-19.42%3 083
ULTRAGENYX PHARMACEUTI..-33.42%3 052
BEIJING SL PHARMACEUTI..--.--%2 985
PEPTIDREAM INC39.82%2 800
GW PHARMACEUTICALS PLC85.37%2 728
BIOCON LTD79.17%2 692
BLUEBIRD BIO INC8.61%2 561
ARIAD PHARMACEUTICALS,..115.68%2 538
KITE PHARMA INC-17.35%2 530
Sector Bio Therapeutic Drugs
Vertex Pharmaceuticals Inc : Connections
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem